Logo image of IR

INGERSOLL-RAND INC (IR) Stock Fundamental Analysis

NYSE:IR - New York Stock Exchange, Inc. - US45687V1061 - Common Stock - Currency: USD

83.69  -3.08 (-3.55%)

After market: 83.69 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IR. IR was compared to 128 industry peers in the Machinery industry. IR has an excellent profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, IR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IR was profitable.
IR had a positive operating cash flow in the past year.
IR had positive earnings in 4 of the past 5 years.
In the past 5 years IR always reported a positive cash flow from operatings.
IR Yearly Net Income VS EBIT VS OCF VS FCFIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.66%, IR is in line with its industry, outperforming 55.20% of the companies in the same industry.
IR has a Return On Equity (8.24%) which is in line with its industry peers.
With a Return On Invested Capital value of 6.90%, IR perfoms like the industry average, outperforming 53.60% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IR is below the industry average of 11.00%.
The 3 year average ROIC (6.11%) for IR is below the current ROIC(6.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.66%
ROE 8.24%
ROIC 6.9%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.11%
ROIC(5y)4.65%
IR Yearly ROA, ROE, ROICIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

With a decent Profit Margin value of 11.59%, IR is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Profit Margin of IR has grown nicely.
The Operating Margin of IR (20.12%) is better than 87.20% of its industry peers.
IR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 43.81%, IR is in the better half of the industry, outperforming 79.20% of the companies in the same industry.
IR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.12%
PM (TTM) 11.59%
GM 43.81%
OM growth 3Y14.56%
OM growth 5Y7.08%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
IR Yearly Profit, Operating, Gross MarginsIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

IR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IR remains at a similar level compared to 1 year ago.
Compared to 5 years ago, IR has more shares outstanding
Compared to 1 year ago, IR has a worse debt to assets ratio.
IR Yearly Shares OutstandingIR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
IR Yearly Total Debt VS Total AssetsIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

IR has an Altman-Z score of 3.70. This indicates that IR is financially healthy and has little risk of bankruptcy at the moment.
IR has a better Altman-Z score (3.70) than 61.60% of its industry peers.
The Debt to FCF ratio of IR is 3.81, which is a good value as it means it would take IR, 3.81 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IR (3.81) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.47 indicates that IR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, IR is in line with its industry, outperforming 46.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.81
Altman-Z 3.7
ROIC/WACC0.66
WACC10.47%
IR Yearly LT Debt VS Equity VS FCFIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 2.29 indicates that IR has no problem at all paying its short term obligations.
The Current ratio of IR (2.29) is comparable to the rest of the industry.
IR has a Quick Ratio of 1.71. This is a normal value and indicates that IR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of IR (1.71) is better than 71.20% of its industry peers.
Industry RankSector Rank
Current Ratio 2.29
Quick Ratio 1.71
IR Yearly Current Assets VS Current LiabilitesIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.15% over the past year.
IR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.65% yearly.
The Revenue has been growing slightly by 5.22% in the past year.
Measured over the past years, IR shows a very strong growth in Revenue. The Revenue has been growing by 29.10% on average per year.
EPS 1Y (TTM)11.15%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-2.33%
Revenue 1Y (TTM)5.22%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%4.24%

3.2 Future

The Earnings Per Share is expected to grow by 11.38% on average over the next years. This is quite good.
IR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.37% yearly.
EPS Next Y7.9%
EPS Next 2Y9.03%
EPS Next 3Y8.95%
EPS Next 5Y11.38%
Revenue Next Year4.31%
Revenue Next 2Y4.97%
Revenue Next 3Y4.86%
Revenue Next 5Y7.37%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IR Yearly Revenue VS EstimatesIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
IR Yearly EPS VS EstimatesIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

IR is valuated quite expensively with a Price/Earnings ratio of 25.44.
IR's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 29.63. IR is around the same levels.
With a Price/Forward Earnings ratio of 23.57, IR is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as IR.
IR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.44
Fwd PE 23.57
IR Price Earnings VS Forward Price EarningsIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IR.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 27.03
EV/EBITDA 19.71
IR Per share dataIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IR does not grow enough to justify the current Price/Earnings ratio.
IR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.22
PEG (5Y)1.63
EPS Next 2Y9.03%
EPS Next 3Y8.95%

3

5. Dividend

5.1 Amount

IR has a yearly dividend return of 0.09%, which is pretty low.
Compared to an average industry Dividend Yield of 1.67, IR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.29, IR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.09%

5.2 History

IR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of IR decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
IR Yearly Dividends per shareIR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

3.85% of the earnings are spent on dividend by IR. This is a low number and sustainable payout ratio.
DP3.85%
EPS Next 2Y9.03%
EPS Next 3Y8.95%
IR Yearly Income VS Free CF VS DividendIR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
IR Dividend Payout.IR Dividend Payout, showing the Payout Ratio.IR Dividend Payout.PayoutRetained Earnings

INGERSOLL-RAND INC

NYSE:IR (2/21/2025, 8:04:00 PM)

After market: 83.69 0 (0%)

83.69

-3.08 (-3.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners100.1%
Inst Owner Change-2.45%
Ins Owners0.18%
Ins Owner Change6.05%
Market Cap33.73B
Analysts77.6
Price Target105 (25.46%)
Short Float %2.11%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield 0.09%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP3.85%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-05 2025-03-05 (0.02)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.48%
Min EPS beat(2)-3.21%
Max EPS beat(2)0.25%
EPS beat(4)3
Avg EPS beat(4)2.44%
Min EPS beat(4)-3.21%
Max EPS beat(4)9.69%
EPS beat(8)7
Avg EPS beat(8)7.24%
EPS beat(12)11
Avg EPS beat(12)6.52%
EPS beat(16)15
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-3.45%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)-2.68%
Revenue beat(8)3
Avg Revenue beat(8)-0.55%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)9
Avg Revenue beat(16)-0.95%
PT rev (1m)-4.44%
PT rev (3m)-0.24%
EPS NQ rev (1m)-1.12%
EPS NQ rev (3m)-0.87%
EPS NY rev (1m)-0.29%
EPS NY rev (3m)-0.27%
Revenue NQ rev (1m)-1.21%
Revenue NQ rev (3m)-1.11%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE 25.44
Fwd PE 23.57
P/S 4.66
P/FCF 27.03
P/OCF 24.15
P/B 3.31
P/tB N/A
EV/EBITDA 19.71
EPS(TTM)3.29
EY3.93%
EPS(NY)3.55
Fwd EY4.24%
FCF(TTM)3.1
FCFY3.7%
OCF(TTM)3.47
OCFY4.14%
SpS17.95
BVpS25.26
TBVpS-5.81
PEG (NY)3.22
PEG (5Y)1.63
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 8.24%
ROCE 8.99%
ROIC 6.9%
ROICexc 7.63%
ROICexgc 52.5%
OM 20.12%
PM (TTM) 11.59%
GM 43.81%
FCFM 17.24%
ROA(3y)4.58%
ROA(5y)3.45%
ROE(3y)7.59%
ROE(5y)5.73%
ROIC(3y)6.11%
ROIC(5y)4.65%
ROICexc(3y)6.87%
ROICexc(5y)5.28%
ROICexgc(3y)44.6%
ROICexgc(5y)34.82%
ROCE(3y)7.96%
ROCE(5y)6.06%
ROICexcg growth 3Y18.6%
ROICexcg growth 5Y18.94%
ROICexc growth 3Y18.6%
ROICexc growth 5Y4.1%
OM growth 3Y14.56%
OM growth 5Y7.08%
PM growth 3Y2.02%
PM growth 5Y8.01%
GM growth 3Y4.32%
GM growth 5Y2.58%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.81
Debt/EBITDA 2.45
Cap/Depr 30.93%
Cap/Sales 2.06%
Interest Coverage 250
Cash Conversion 72.08%
Profit Quality 148.77%
Current Ratio 2.29
Quick Ratio 1.71
Altman-Z 3.7
F-Score6
WACC10.47%
ROIC/WACC0.66
Cap/Depr(3y)25.25%
Cap/Depr(5y)20.22%
Cap/Sales(3y)1.73%
Cap/Sales(5y)1.5%
Profit Quality(3y)146.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.15%
EPS 3Y15.06%
EPS 5Y15.65%
EPS Q2Q%-2.33%
EPS Next Y7.9%
EPS Next 2Y9.03%
EPS Next 3Y8.95%
EPS Next 5Y11.38%
Revenue 1Y (TTM)5.22%
Revenue growth 3Y11.98%
Revenue growth 5Y29.1%
Sales Q2Q%4.24%
Revenue Next Year4.31%
Revenue Next 2Y4.97%
Revenue Next 3Y4.86%
Revenue Next 5Y7.37%
EBIT growth 1Y17.25%
EBIT growth 3Y28.28%
EBIT growth 5Y38.24%
EBIT Next Year21.77%
EBIT Next 3Y13.33%
EBIT Next 5Y12.29%
FCF growth 1Y-1.92%
FCF growth 3Y31.28%
FCF growth 5Y32.51%
OCF growth 1Y1.4%
OCF growth 3Y31.41%
OCF growth 5Y32.4%